DOCSLIB.ORG

How to Find Us & Our Recommendations For

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
How to Find Us & Our Recommendations For How to find Us & Our Recommendations for Accommodation How to find us Our address: Eurofins BioPharma Product Testing Munich GmbH & BSL BIOSERVICE Scientific Laboratories Munich GmbH Robert-Koch-Strasse 3A 82152 Planegg/Munich Germany From Munich Airport By Car Use Highway A92 direction Munich. At “Autobahnkreuz Neufahrn” take direction A8 “Stuttgart / München-West“. At Dreieck “München Feldmoching” keep left direction A 99 “Stuttgart / Augsburg / Lindau / München-West”. At Dreieck “München-Süd-West” follow A96 direction “Lindau / Memmingen / Germering Süd”. Leave the highway at exit “Germering Süd” and turn left direction “Planegg / Krailling”. In “Planegg” turn left into “Pasinger Straße”. Follow Sign “Gewerbegebiet Steinkirchen” by taking the second exit of the roundabout into “Semmelweisstraße”. Turn the second right into “Robert – Koch – Strasse” and follow this street to the left. Straight ahead is the Eurofins BioPharma Product Testing building. By Public Transport S-Bahn Line S8 Take S8 from the airport to station “Marienplatz” (train-ride about 40 minutes). Change to the Subway U6 direction “Klinikum Großhadern” and exit at station “Großhadern”. Take the bus route 268 in the direction “Gräfelfing Bahnhof” and change at “Gräfelfing, Pasinger Strasse” to bus route 265 in direction “Planegg”. Get off at “Steinkirchen” and go right into “Robert – Koch – Strasse” continue straight ahead towards the Eurofins BioPharma Product Testing building. S-Bahn Line S1 Take S1 from the airport, direction “Ostbahnhof” and exit at station “Laim”. Change to S6 direction „Starnberg / Tutzing“. Get out at station “Planegg” and take the bus route 265. Get out at “Steinkirchen”. Go right into “Robert – Koch – Strasse” and go straight ahead towards the Eurofins BioPharma Product Testing building. From Munich Center By Car Pass “Gräfelfing” on the main road and follow the direction “Planegg”; turn left at the boundary of “Planegg”. Follow Sign “Gewerbegebiet Steinkirchen” by taking the second exit of the roundabout into “Semmelweisstraße”. Turn the second right into “Robert – Koch – Strasse” and follow this street to the left. Straight ahead is the Eurofins BioPharma Product Testing building. By Public Transport Take at station “Marienplatz” the Subway U6 direction “Klinikum Großhadern” and exit at station “Großhadern”. Take the bus route 265 in the direction “Planegg” and get off at “Steinkirchen”. Go right into “Robert – Koch – Strasse” and go straight ahead towards the Eurofins BioPharma Product Testing building. We are looking forward to meeting you! Accommodation It is our pleasure to recommend a few hotels for your visit at Eurofins or BSL Munich. The accommodations listed below are not far from Eurofins/BSL (5 minutes by car/taxi) and close to the train station Planegg. From there you just have a 20 minute ride to the main station in Munich. Parkhotel Leiser (first choice, rooms garden side) Bahnhofstrasse 26 D-82152 Planegg Tel: +49 (0) 89 600 876 70 Email: [email protected] Internet: www.parkhotel-leiser.de Hotel Asemann Planegg (family hotel) Gumstrasse 13 D-82152 Planegg Tel.: +49 (0) 89 899 676 0 Fax: +49 (0) 89 859 601 6 Email: [email protected] Internet: http://www.hotel-planegg.de/ IZB Residence- Campus At Home Am Klopferspitz 21 D-82152 Planegg/Martinsried Internet: http://www.izb-online.de/de/izb-residence-campus-at-home.html Reservations [email protected] Ruthellens Home (bed & breakfast) Hofmarkstraße 37 D-82152 Planegg Tel.: +49 (0) 89 897 452 23 Email: [email protected] Internet: http://www.ruthellens-home.de/ If you have any further question, please do not hesitate to contact us any time. Please let us know if you need any help with the reservation. We are looking forward to your visit. Eurofins BioPharma Product Testing Munich GmbH & BSL BIOSERVICE Scientific Laboratories Munich GmbH .
Load more

Recommended publications
  • Press Release, September 10, 2019 MPIB-Emeritus Axel Ullrich Is
    public relations Press Release, September 10, 2019 dr. christianechristiane menzfeld menzfeld tel.: +49 89 8578-2824 phone: +49 89 8578-2824 [email protected] [email protected] www.biochem.mpg.de/news www.biochem.mpg.de/news @MPI_Biochem MPIB-Emeritus Axel Ullrich is awarded with Lasker Award 2019 Axel Ullrich, together with H. Michael Shepard and Dennis J. Slamon, receives the highest biomedical scientific award in the United States for the invention of Herceptin. Herceptin was the first monoclonal antibody that blocks a cancer causing protein. For the invention of Herceptin and the development of a life-saving therapy for women with breast cancer, three researchers are now receiving the Lasker~DeBakey Clinical Medical Research Award: Axel Ullrich, Emeritus Director at the Max Planck Institute of Biochemistry and former Genentech scientist, H. Michael Shepard, former Genentech scientist and Dennis J. Slamon from the University of California, Los Angeles. The prize is the highest biomedical scientific award in the USA and is awarded with 250,000 US dollars. The award ceremony will take place in New York City on Friday, September 20. In the mid-1970s, scientists discovered that certain genes, when mutated, can cause cancer; researchers theorized that targeting these oncogenes, or the proteins they code for, could prevent the spread of malignancies. The combined efforts of H. Michael Shepard, Dennis J. Slamon, and Axel Ullrich culminated in the creation of Herceptin, the first monoclonal antibody therapy that targets a protein encoded by an oncogene. Monoclonal antibodies are proteins that bind to specific invader organisms or abnormal (e.g.
    [Show full text]
  • Die Bibliothek Zum Downloaden
    DigiBObb. Digitale Bibliothek Oberbayern DigiBObb. - Partner Gemeindebücherei Eichenau Gemeindebücherei Planegg Tel.: 08141 82183 Tel.: 089 89926-286 www.gemeindebuecherei-eichenau.de www.planegg.de/buecherei Die Bibliothek Stadtbibliothek Fürstenfeldbruck Stadtbibliothek Puchheim Tel.: 08141 3630910 Tel: 089 80098-115 zum Downloaden www.stadtbibliothek-fuerstenfeldbruck.de www.puchheim.de Überall. Jederzeit. Kostenfrei. Gemeindebücherei Gauting Gemeindebücherei Taufkirchen Tel: 089 89337-132 Tel.: 666722-171 www.gauting.de/buecherei www.taufkirchen.de www.digibobb.de Stadtbibliothek Germering Gemeindebücherei Unterhaching Tel.: 089 8944510 Tel: 089 66551-440 www.germering.de/bibliothek www.unterhaching.de Gemeindebücherei Gräfelfing Tel: 089 858273 www.buecherei-graefelfing.de Impressum Gemeindebibliothek Neubiberg Herausgeber: DigiBObb. Tel.: 089 60012-70 www.neubiberg.de Grafik/Layout: flowconcept Agentur für Kommunikation GmbH Gemeinde- und Schulbibliothek Oberhaching www.flowconcept.de Tel.: 089 61377-155 Stand: November 2015 www.oberhaching.de Gemeindebibliothek Ottobrunn Tel.: 089 60808-500 www.ottobrunn.de DigiBObb. Digitale Bibliothek Oberbayern DigiBObb. – wie funktioniert das? DigiBObb. - was ist das? Anmeldung DigiBObb. ist das digitale Medienangebot Unter www.digibobb.de mit Benutzernummer der Bibliotheken Eichenau, Fürstenfeldbruck, und Passwort. Gauting, Germering, Gräfelfing, Neubiberg, DigiBObb. - das digitale Oberhaching, Ottobrunn, Planegg, Puchheim, Medienangebot Ausleihe Taufkirchen und Unterhaching. Die Suche erfolgt
    [Show full text]
  • Relevance for Institutes of the Max Planck Society
    E-iRODS" Relevance for Institutes of the Max Planck Society" 1! SC12, Salt Lake City! Hermann Lederer, RZG! Max Planck Society Max PlanckThe Max Society Planck Society for the Advancement of Science is an independent, non-profit research organization that primarily promotes and supports research at its own institutes. The research institutes perform basic research in the interest of the general public in the natural sciences, life sciences, social sciences, and the humanities. Currently the Max Planck Society maintains 80 institutes, research units, and working groups 2! SC12, Salt Lake City! Hermann Lederer, RZG! Max Planck Society MaxMany Planck institutes Society of the Max Planck Society are engaged in international collaborations with data involvements This includes institutes from all three main areas of research within the MPS: •" Chemistry, Physics & Technology •" Biology and Medicine •" Humanities and Social Sciences 3! SC12, Salt Lake City! Hermann Lederer, RZG! Max Planck Society Max Planck Society 4! SC12, Salt Lake City! Hermann Lederer, RZG! MPS – Chemistry, Physics & Technology Data from fusion energy research - plasma physics Experiment data of Asdex Upgrade, MPI for Plasma Physics Generated at Garching, Germany Experiment data of W7-X, MPI for Plasma Physics, to be generated at Greifswald, Germany as of 2014 Experiment data of ITER, to be generated at Cadarache, France With involvement of MPI for Plasma Physics Supercomputing data of IFERC, Rokkasho, Japan, with involvement of MPI for Plasma Physics 5! SC12, Salt Lake City! Hermann Lederer, RZG! MPS – Chemistry, Physics & Technology Magic Project – Data from Telescopes Gamma Ray Astronomy Involvement of MPI for Physics, Munich Pan-STARRS -- the Panoramic Survey Telescope & Rapid Response System -- is an innovative design for a wide-field imaging facility developed at the University of Hawaii's Institute for Astronomy.
    [Show full text]
  • Gut Unterwegs in Garching Mobilität Im Landkreis Wird Noch Einfacher
    Gut unterwegs in Garching Mobilität im Landkreis wird noch einfacher BUS Inhalt Die MVV-Tarifreform auf einen Blick 4 Die Zone M: Größer als der jetzige Innenraum 5 Einheitliche Tariflogik 6 Das Tarifsystem 8 Verbindungen vor Ort 10 MVV Regionalbus 12 MVG Rad 14 Weitere Mobilitätsangebote 16 Das Carsharing System 17 Nützliche Apps 18 Mobilitätsprojekte im Landkreis München 20 Impressum Dezember 2019 Herausgeber Bildrechte Landratsamt München Landratsamt München Presse- und Öffentlichkeitsarbeit MVV GmbH Mariahilfplatz 17 Stadt Garching 81541 München Tel.: 089 / 6221 - 1600 Konzept und Gestaltung E-Mail: [email protected] flowconcept Internet: www.landkreis-muenchen.de Agentur für Kommunikation GmbH www.flowconcept.de V.i.S.d.P.: Christine Spiegel Druck Redaktion Druck-Ring GmbH & Co. KG, Christine Spiegel, Christina Walzner in Kirchheim bei München Zusammenarbeit mit Mitarbeitern des www.druck-ring.de Landratsamts 2 GRUSSWORT Liebe Garchingerinnen und Garchinger, wer kennt es nicht? Nur mal schnell mit dem Auto zum Ein- kaufen in die Stadt oder morgens zum Arbeitsplatz – und schon ist man in die Staufalle getappt: Autos wohin man blickt, an zügiges Vorwärtskommen ist nicht zu denken. Aber das muss nicht sein. Um im Landkreis gut und günstig von A nach B zu kommen, gibt es zahlreiche alternative Mobilitätsangebote. Ob klas- sisch mit dem ÖPNV, gesellig in einer Fahrgemeinschaft oder – gerade bei kurzen Strecken – mit dem (MVG) Rad. In Christoph Göbel Zukunft radeln Sie sogar in gut 30 Minuten auf der ersten Landrat Radschnellverbindung im Landkreis bis nach München. Oft sind Sie ohne eigenen PKW deutlich schneller und günstiger unterwegs. Obendrein wird dabei nicht nur Ihr Geldbeutel geschont, sondern auch die Umwelt.
    [Show full text]
  • Curriculum Vitae Professor Dr. Wolfgang Baumeister
    Curriculum Vitae Professor Dr. Wolfgang Baumeister Name: Wolfgang Baumeister Born: 22 November 1946 Main areas of research: Structure and function of molecular machines, in particular supramolecular assemblies involved in protein quality control , e.g. 26S proteasome Academic and Professional Career since 2000 Honorary Professor, Faculty of Physics, Technical University, Munich, Germany since 1988 Director, Max Planck Institute of Biochemistry, Head of Department of Structural Biology, Martinsried, Germany since 1987 Professor (apl.), Faculty of Chemistry, Technical University, Munich, Germany 1984 - 1987 Professor (apl.), University of Düsseldorf, Germany 1983 - 1987 Group Leader (C3), Max Planck Institute of Biochemistry, Martinsried, Germany 1978 Habilitation; venia legendi in Biophysics 1973 - 1980 Research Associate, Dept. of Biophysics, University of Düsseldorf, Germany 1970 - 1973 Ph.D., University of Düsseldorf, Germany 1967 - 1969 University of Bonn (Biology, Chemistry, Physics), Germany 1966 - 1967 University of Münster (Biology, Chemistry, Physics), Germany Project coordination, Membership in collaborative research projects since 2010 Honorary Board Member of the Journal of Electron Microscopy Nationale Akademie der Wissenschaften Leopoldina www.leopoldina.org 1 since 2008 Co-editor: Encyclopedia of Biological Chemistry, Elsevier since 2006 Editor: Biochemical and Biophysical Research Communications since 2005 Editorial Board Member: Journal of Microscopy since 2003 Editorial Board Member: Trends in Cell Biology since 2003
    [Show full text]
  • Sales Specialist - Back Office (M/F/D)
    CAREERS JOIN OUR TEAM Sales Specialist - Back Office (m/f/d) Munich (Martinsried/Planegg) / Germany Full-time (40 h/week) or part-time (20 h/week) We are a growing provider of bioanalytical instruments for the development of new drugs against cancer and other diseases. Our cutting-edge scientific instruments are used by customers in pharma, biotech, and academia. We are seeking highly motivated individuals to manage our sales back office. Based in our headquarters in Martinsried, you will be collaborating closely with our Technical Sales Team and Application Specialists in the field to organize and implement sales activities. FUNCTIONS • Support of sales team in day-to-day operations: preparation of quotes, confirmations, invoices; participation in tenders • Management of order, delivery, and payment processes; including documentation • Use and administration of ERP and CRM systems • Management of logistics, shipping, and customs • Optimization and development of sales-related processes • Support the sales team with inside sales-related activities such as prospecting and supporting the marketing Team with email campaigns QUALIFICATIONS and SKILLS • Degree in business administration or life sciences • Experience in sales, either in the back office or in the field • Good organizational and communication skills • Excellent command of English and German • Experience with ERP systems (myfactory, SAP, or similar) and CRM systems (vtiger, Salesforce, or similar) will be considered an advantage • Proficiency with MS Office www.dynamic-biosensors.com CAREERS JOIN OUR TEAM WE OFFER • a fun and dynamic work environment in a young, multicultural team • diversified and fast-paced projects, a stimulating and ever-challenging environment • competitive compensation and the possibility for career development alongside a growing team CONTACT US Please send your application and CV as a single PDF document to Daisyléa de Souza Paiva, PhD / [email protected] Please reference: Job ID = Sales Specialist, March 2021 DISCOVER MOLECULAR INTERACTIONS! Together.
    [Show full text]
  • Industrial Market Profile
    Industrial Market Profile Munich | 4th quarter 2019 January 2020 Industrial Market Profile | 4th quarter 2019 Munich Warehousing Take-up Munich's logistics market cannot exploit demand potential The high demand for warehousing and logistics space in the Munich region* slowed down in 2019 due to the lack of available space and land. As expected, with 219,000 sqm (including owner-occupiers), the take-up result was signifi- cantly below the previous year's level (-22%) and the five- year average (-13%). Thanks to two large deals of over 10,000 sqm, almost half of the annual take-up volume was generated in the third quarter. In general, however, few ma- jor searches can be satisfied due to the lack of available space and land. bach (by an owner-occupier). With 30 contracts signed and Compared to 2018, over 50% less space was taken up in the a 40% share of take-up, most market activities took place in > 5,000 sqm size category. By the end of the year, just seven Periphery North, followed by Periphery East with 25 contracts deals had been concluded in this segment. In addition to signed and 31% of the take-up volume. a letting of 30,000 sqm of projected new space in Parsdorf Due to the lack of available land, 46,000 sqm of new space (BMW), this included a new 15,000 sqm project in Langen- was completed in 2019, around 41% less than in the previ- ous year. The volume of new construction suggests that the market situation will not ease in the coming months.
    [Show full text]
  • Medigene AG Planegg/Martinsried SIN: A1X3W0 ISIN: DE000A1X3W00 We Hereby Invite Our Shareholders to the Annual General Meeting
    Medigene AG Planegg/Martinsried SIN: A1X3W0 ISIN: DE000A1X3W00 We hereby invite our shareholders to the Annual General Meeting, which will be held at Haus der Bayerischen Wirtschaft (HBW), Europasaal, Max-Joseph-Strasse 5, 80333 Munich, Germany at 11:00 a.m. (CEST) on Wednesday, May 22, 2019. Agenda 1. Presentation of the adopted annual financial statements as of December 31, 2018, the approved consolidated financial statements as of December 31, 2018, the management report for the financial year 2018, the Group management report for the financial year 2018, the report of the Supervisory Board for the financial year 2018 and the explanatory report of the Executive Management Board on the statements pursuant to Section 289a (1) and Section 315a (1) of the German Commercial Code (HGB) On March 26, 2019, the Supervisory Board approved the annual financial statements prepared by the Executive Management Board and the consolidated financial statements prepared by the Executive Management Board. The annual financial statements have therefore been adopted pursuant to Section 172 Sentence 1 of the German Stock Corporation Act (AktG). The Annual General Meeting must have access to the annual financial statements, the management report, the consolidated financial statements, the Group management report, the report of the Supervisory Board and the report of the Executive Management Board on the statements pursuant to Sections 289a (1) and 315a (1) of the German Commercial Code (HGB). No resolution will be passed on this item of the Agenda. 2. Discharge of the Executive Management Board members from their responsibilities for financial year 2018 The Executive Management Board and Supervisory Board propose to discharge all members of the Executive Management Board for the financial year 2018.
    [Show full text]
  • Peptide Chemistry in Martinsried
    .... THETHE EUROPEANEUROPEAN PEPTIDEPEPTIDE SOCIETYSOCIETY NEWSLETTERNEWSLETTER ISSUEISSUE NUMBERNUMBER 34,34, 11 JANUARYJANUARY 20062006 The Max–Planck–Institute of Biochemistry Peptide Chemistry in Martinsried International Symposium on VIP, PACAP and Related Peptides ñ Bulgarian Peptide Symposium ñ Polish Peptide Symposium ñ Dutch Peptide Day ñ Workshop in Berlin .... THE EUROPEAN PEPTIDE SOCIETY NEWSLETTER from the editor ISSUEISSUE NUMBERNUMBER 34,34, 11 JANUARYJANUARY 20062006 A message Dear Colleagues and Friends, This issue of the Newsletter is the last of the se- ries of this edition in its present paper–based The Max-Planck-Institute of Biochemistry form. During the Executive Committee meeting Peptide Chemistry in Martinsried of EPS, held at Eötvös University in Budapest on International Symposium on VIP, PACAP and Related Peptides ñ Bulgarian Peptide Symposium ñ Polish Peptide Symposium ñ Dutch Peptide Day ñ Workshop in Berlin the 5th November 2005, a number of solutions Cover photo: The Max–Planck–Institute for the future of the printed version of the of Biochemistry, Martinsried Newsletter were discussed and different opin- ions were expressed regarding not only the In this issue: Newsletter but also the Society’s website re- Peptide Chemistry duced visitors count, maybe as a result of this in Martinsried ........................................ 4 co–existence of different media. As the Newslet- International Symposium on VIP, ter editor I strongly emphasized on the neces- PACAP and Related Peptides............ 6 sity for the Society to have a printed medium Bulgarian Peptide Symposium ....... 8 and of course I expressed my views on the dis- Polish Peptide Symposium ............. 9 tinct and not overlapping roles of the printed Newsletter and the web site of EPS.
    [Show full text]
  • Biotech in Bavaria
    20 BIOTECH IN BAVARIA REPORT 2016/17 including more than 300 company managed by profiles and contact addresses 291 m 99 m 10 nm 2962 m Gipfelstürmern bieten wir in Penzberg die beste Basis. Roche in Penzberg ist aktiver Teil der Life-Science-Region Greater Munich. Als Powerhouse für Antikörper haben wir hohe Ziele. Mit Mut zu neuen Ideen, dem Willen zur Lösung drängender Gesundheitsfragen und gelebter kultureller Vielfalt arbeiten wir global vernetzt an den Gesundheitslösungen von morgen. From Science to Patients. accelerating biomedical innovation BioM – central point of contact for pharma and biotechnology in Munich and Bavaria ❚ consulting for founders-to-be, ❚ representing Bavarian biotechnology start-ups & SMEs world-wide ❚ grant & seed fi nancing support ❚ investment opportunities ❚ pre-seed incubation & m4 award ❚ central online platform: ❚ matchmaking, networking & partnering job exchange, company database ❚ events, conferences & training and much more www.bio-m.org accelerating biomedical innovation M Bio – central point of contact for Imprint Editorial staff: Dr. Almut Windhager, pharma and biotechnology in Munich Dr. Georg Kääb Company Profiles: Dr. Christina Grimm Dr. Andreas Berghammer and Bavaria Data analysis was compiled together with BIO-Deutschland e.V., special thanks to Nicole Kukuk and Florian Matznick. ❚ consulting for founders-to-be, ❚ representing Bavarian biotechnology We thank the Bavarian companies and the regional organizations of the Bavarian Biotechnology Cluster for start-ups & SMEs world-wide supporting this
    [Show full text]
  • Biotech in Bavaria Transformation in Progress
    BIOTECH IN BAVARIA TRANSFORMATION IN PROGRESS REPORT 2018/19 including more than 300 company managed by profiles and contact details Future X Healthcare e digital (r)evolution – a new era for patients 14 November 2019 | Munich www.fxh2019.com accelerating biomedical innovation BioM – central point of contact for pharma and biotechnology in Munich and Bavaria ❚ consulting for founders-to-be, ❚ representing Bavarian biotechnology start-ups & SMEs world-wide ❚ grant & seed fi nancing support ❚ investment opportunities ❚ pre-seed incubation & m4 award ❚ central online platform: ❚ matchmaking, networking & partnering job exchange, company database ❚ events, conferences & training and much more www.bio-m.org Bavarian Ministry ofBavarian Ministry of Economic Aairs, Economic Aairs, Regional DevelopmentRegional Development and Energy and Energy Never stop exploring. Be part of the digital future. Right this way for R&D Bavaria is the leading biotech and pharma location in Germany. With a high number of international pharma companies and new rising biotech stars, Bavaria offers the right environment and infrastructure for your company – especially when it comes to R&D. In Bavaria you’ll find the right ingredients: a wealth of potential partners and customers throughout the entire industry value chain and highly qualified personnel. Bavaria is the home of digital future and your perfect business location. Discover the benefits of expanding your business to Bavaria. We do everything to get your business started: From arranging contacts with relevant players to identifying the perfect location for your company. Our service is confidential and free of charge. Get in touch with us! • www.invest-in-bavaria.com IB-Bio-Tech-AZ-A4-2019.indd 1 19.02.19 16:19 CONTENT Greeting 5 Hubert Aiwanger, Bavarian State Minister of Economic Affairs, Regional Development and Energy Preface - Biotechnology in Transformation 7 Prof.
    [Show full text]
  • NASA Buys Into the Action on Keck Telescope
    NEWS NASA buys into the action on Keck telescope Washington. The US National Aeronautics stars. Keck may also be able directly to Until recently, the ASEPS programme and Space Administration (NASA) is close image Jupiter-sizeplanets around nearby stars. was known as TOPS (Toward Other Plan­ to signing an agreement with the California An outside advisory group was due to etary Systems). But NASA managers, wor­ consortium that operates the Keck telescope, meet in Washington this week to advise ried that TOPS had become tainted when the largest optical instrument in the world, NASA on how the ASEPS programme Congress cut the Search for Terrestrial In­ under which the space agency will pay one­ should be run. The current plan, according telligence (SETI) programme from the agen­ sixth of the Hawaiian observatory's con­ to Jurgen Rahe of the agency's solar system cy's budget last year, decided to change the struction costs in exchange for an equal exploration division, is to establish a core name. They say they are confident that the proportion of viewing time. team that makes on-going observations, astronomical search for other planets, un­ NASA will use the two 10-metre Keck while funding individual investigators to like SETI, should be safe from political telescopes, the second of which is scheduled conduct specific research projects in attack - or at least as safe as any other to be completed in 1996, for a long-term extrasolar planet detection. project in Washington. Tony Relchhardt programme to search for planets around other stars. One-third of the viewing time on the Keck II telescope will be dedicated to Bavaria bids for key role in biotech that search.
    [Show full text]